DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
National Cancer Institute (NCI)
NRG Oncology
Aulos Bioscience, Inc.
Gilead Sciences
Hospital of Macerata
Maastricht University Medical Center
Centre Francois Baclesse
Queen Mary University of London
Erasmus Medical Center